The Patent Finder
SP

Sonoma Pharmaceuticals, Inc.

First filing 2002
OverviewNotableFeesChangesFamiliesPatent listSources & methods

Previously recorded as Oculus Innovative Sciences, Inc. (to 2017)

Seven patents currently held, every record listed here

2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

The next term ends in Jan 2027. from the record

Of the 2 now held by other companies, 2 name Microsafe Group DMCC as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
5
Ending by 2030
Jan 2027
Next term end
6
Patent families

When these terms end

Each bar runs from grant to computed term end. 2014 to 2034.
US 9,072,726 Methods of Treating or Preventing Inflammation and Hypersensitivity with Oxidative Reductive Potential Water Solution Jan 22, 2027
US 8,834,445 Methods of Treating or Preventing Peritonitis with Oxidative Reductive Potential Water Solution Jan 22, 2027
US 9,782,434 Methods of Treating or Preventing Inflammation and Hypersensitivity with Oxidative Reductive Potential Water Solution Jan 22, 2027
US 8,840,873 Method of Treating Second and Third Degree Burns Using Oxidative Reductive Potential Water Solution Oct 24, 2027
US 8,784,900 Antimicrobial Solutions Containing Dichlorine Monoxide and Methods of Making and Using the Same Jun 1, 2029
US 10,342,825 Solution Containing Hypochlorous Acid and Methods of Using Same Jun 15, 2030
US 10,265,341 Hydrogel formulation comprising oxidative reductive potential water Jul 30, 2030
US 9,918,477 Stabilized Hypochlorous Acid Solution and Use Thereof May 22, 2034
US 10,412,969 Stabilized Hypochlorous Acid Solution and Use Thereof May 22, 2034
20182022202620302034
Every computed term in this portfolio is shown above.Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Hydrogel formulation comprising oxidative reductive potential water US 10,265,341
Cited by 47 later US patents, top 5% of utility patents granted in 2019 in our data. Protection runs to 2030.
Ends Jul 2030 · High confidence
Also notable
Methods of Treating or Preventing Inflammation and Hypersensitivity with Oxidative Reductive Potential Water Solution US 9,072,726
Cited by 28 later US patents, top 25% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2027. A terminal disclaimer caps this term to an earlier patent's.
Ends Jan 2027 · Low confidence
Also notable
Stabilized Hypochlorous Acid Solution and Use Thereof US 9,918,477
Cited by 13 later US patents, top 25% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2034.
Ends May 2034 · High confidence

Formerly held, still cited

Notable
Cited by 53 later US patents, top 10% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
Ends Jun 2029 · High confidence

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 9, 2027
    The maintenance fee for Solution Containing Hypochlorous Acid and Methods of Using Same (US 10,342,825) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
  • 1 fee due Mar 17, 2027
    The maintenance fee for Stabilized Hypochlorous Acid Solution and Use Thereof (US 10,412,969) comes due Mar 17, 2027. Unpaid by Sep 17, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

What they patent

The 5 largest of its 6 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.

Patents held now

Soonest term end first.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatusExpiresConfidence
US 8,834,445Methods of Treating or Preventing Peritonitis with Oxidative Reductive Potential Water Solution
In force
 · High confidence
In forceHigh confidence
US 9,072,726Methods of Treating or Preventing Inflammation and Hypersensitivity with Oxidative Reductive Potential Water Solution
In force
 · Low confidence
In forceLow confidence
US 8,840,873Method of Treating Second and Third Degree Burns Using Oxidative Reductive Potential Water Solution
In force
 · High confidence
In forceHigh confidence
US 10,342,825Solution Containing Hypochlorous Acid and Methods of Using Same
In force
 · High confidence
In forceHigh confidence
US 10,265,341Hydrogel formulation comprising oxidative reductive potential water
In force
 · High confidence
In forceHigh confidence
US 9,918,477Stabilized Hypochlorous Acid Solution and Use Thereof
In force
 · High confidence
In forceHigh confidence
US 10,412,969Stabilized Hypochlorous Acid Solution and Use Thereof
In force
 · High confidence
In forceHigh confidence
Also on record, not counted in the 7: 2 patents in force now held by others · 12 patents ended · 13 applications abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited